Boston Scientific Corp’s recent filing unveils that its Director Zane Ellen M unloaded Company’s shares for reported $1.42 million on Feb 24 ’25. In the deal valued at $104.23 per share,13,586 shares were sold. As a result of this transaction, Zane Ellen M now holds 34,944 shares worth roughly $3.65 million.
Then, JEFFREY B MIRVISS bought 4,675 shares, generating $487,369 in total proceeds.
Before that, Zane Ellen M bought 13,586 shares. Boston Scientific Corp shares valued at $1,416,088 were divested by the Director at a price of $104.23 per share.
Deutsche Bank upgraded its Boston Scientific Corp [BSX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Needham’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Goldman began covering BSX with “Buy” recommendation on May 30, 2024. Mizuho revised its rating on February 01, 2024. It rated BSX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of BSX
On Friday, Boston Scientific Corp [NYSE:BSX] saw its stock fall -0.10% to $104.39. Over the last five days, the stock has lost -1.62%. Boston Scientific Corp shares have risen nearly 16.87% since the year began. Nevertheless, the stocks have risen 58.77% over the past one year. While a 52-week high of $107.17 was reached on 02/05/25, a 52-week low of $65.52 was recorded on 01/02/25. SMA at 50 days reached $97.66, while 200 days put it at $85.06.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 103.86, which if violated will result in even more drops to 103.32. On the upside, there is a resistance level at 104.94. A further resistance level may holdings at 105.48. The Relative Strength Index (RSI) on the 14-day chart is 62.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.77%. Stochastics %K at 57.28% indicates the stock is a holding.
The most recent change occurred on July 19, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $59 price target.
